Leuprolide Acetate Market Trends

Growth Drivers

Rising Demand for IVF Treatment – It is expected that the growing incidence of infertility owing to lifestyle changes, may drive market growth.
Leuprolide acetate injection is a synthetic gonadotropin-releasing hormone that can be used to mature the eggs for retrieval. Moreover, lupron is an injectable fertility drug that is in the category of GnRH agonists which reduces the production of estrogen and progesterone by the ovaries. Over the past five years, IVF cycles have climbed at a pace of over 23%, and India is now ranked third globally for IVF procedures.
Growing Geriatric Population- Hormone-related disorders are more common in older people, and the rising elderly population is expected to increase the demand for leuprolide acetate since it is used to manage hormonal imbalances.
The number of individuals in the world who are 60 or older will reach over 2 billion by 2050.

Challenges

Risk of Potential Side Effects- Leuprolide acetate may cause several side effects such as breast swelling or tenderness, hot flashes, increased bone pain, increased difficulty passing urine, or an aggravation of nerve symptoms, which may hamper the market growth.
Stringent Price Control Policies
Availability of Alternative Treatments

Leuprolide Acetate Market: Key Insights

Base Year	2022
Forecast Year	2023-2035
CAGR	~7%
Base Year Market Size (2022)	~ USD 2 Billion
Forecast Year Market Size (2035)	~ USD 4 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

Growing cases of cancer across the globe and the growing prevalence of uterus fibroids are the major factors driving the growth of the market.

The market size of Leuprolide Acetate is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023 â€“ 2035.

The major players in the market are AbbVie Inc., Merck & Co., Inc., Taj Pharmaceuticals Limited., Zydus Group, Cipla Inc., Eugia Pharma, Sumitomo Dainippon Pharma, Kyowa Kirin, Takeda Pharmaceutical Company Limited.

The prefilled syringes segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Leuprolide Acetate Market Trends